Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer

Name: Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer
License: Public Domain

Shanghai Zhongshan Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

pancreaticcancer

pancreatic cancer, stage ib, pancreatic cancer, stage iia, pancreatic cancer, stage iib, pancreatic cancer stage iii

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 272364
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.